Expression of alternatively spliced FGF-2 antisense RNA transcripts in the central nervous system: Regulation of FGF-2 mRNA translation

Molecular and Cellular Endocrinology

Volumn 162, Issue 1-2, 2000, Pages 69-78

  Li, Audrey W ^a   Murphy, Paul R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Central nervous system; FGF 2 antisense RNA transcripts; FGF 2 mRNA translation; Regulation

Indexed keywords

COMPLEMENTARY RNA; FIBROBLAST GROWTH FACTOR 2;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DEAMINATION; MESODERM; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA TRANSCRIPTION; RNA TRANSLATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; VASCULAR SMOOTH MUSCLE;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BRAIN; CELL DIVISION; CENTRAL NERVOUS SYSTEM; DNA PRIMERS; DNA, COMPLEMENTARY; FIBROBLAST GROWTH FACTOR 2; GLIOMA; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RATS; RNA, ANTISENSE; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0034712997     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00209-4     Document Type: Article

References (44)

1. Arnaud E., Touriol C., Boutonnet C., Gensac M.-C., Vagner S., Prats H. et al. A new 34-kDa isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol. Cell. Biol. 19:1999;505-514.
2. Basilico C., Moscatelli D. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:1992;115-165.
3. Bass B.L. RNA editing and hypermutation by adenosine deamination. Trends Biochem. Sci. 22:1997;157-162.
4. Bass B.L., Nishikura K., Keller W., Seeburg P.H., Emeson R.B., O'Connell M.A. et al. A standardized nomenclature for adenosine deaminases that act on RNA. RNA. 3:1997;947-949.
5. Borja A.Z.M., Meijers C., Zeller L. Expression of alternatively spliced bFGF first coding exons and antisense mRNAs during chicken embryogenesis. Dev. Biol. 157:1993;110-118.
6. Bredel M., Pollack I.F., Campbell J.W., Hamilton R.L. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas. Clin. Cancer Res. 3:1997;2157-2164.
7. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E. et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 387:1997;303-308.
8. Eckenstein F.P. Fibroblast growth factors in the nervous system. J. Neurobiol. 25:1994;1467-1480.
9. Gagnon M.L., Moy G.K., Klagsbrun M. Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells. J. Cell. Biochem. 72:1999;492-506.
10. Gritti A., Parati E.A., Cova L., Frolichsthal P., Galli R., Wanke E., Faravelli L. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J. Neurosci. 16:1996;1091-1100.
11. Gross J.L., Herblin W.F., Dusak B.A., Czerniak P., Diamond M.D., Sun T. et al. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J. Natl. Cancer Inst. 85:1993;121-131.
12. Grothe C., Meisinger C. Fibroblast growth factor (FGF)-2 sense and antisense mRNA and FGF receptor type 1 mRNA are present in the embryonic and adult rat nervous system. Neurosci. Lett. 197:1995;175-178.
13. Hough R.F., Lingam A.T., Bass B.L. Caenorhabditis elegans mRNAs that encode a protein similar to ADARs derive from an operon containing six genes. Nucleic Acids Res. 27:1999;3424-3432.
14. Kimelman D., Kirschner M.W. An antisense messenger RNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell. 59:1989;687-696.
15. Knee R., Li A., Murphy P.R. Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mRNA and protein. Proc. Natl. Acad. Sci. USA. 94:1997;4943-4947.
16. Knee R., Murphy P.R. Regulation of gene expression by natural antisense RNA transcripts. Neurochem. Int. 31:1997;379-392.
17. Knee R.S., Pitcher S.E., Murphy P.R. Basic fibroblast growth factor sense (FGF) and antisense (gfg) RNA transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues. Biochem. Biophys. Res. Comm. 205:1994;577-583.
18. Kumar M., Carmichael G.G. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. USA. 94:1997;3542-3547.
19. Kumar M., Carmichael G.G. Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol. Mol. Biol. Rev. 62:1998;1415-1434.
20. Li A., Seyoum G., Shiu R., Murphy P.R. Expression of the rat bFGF antisense RNA transcript is tissue-specific and developmentally regulated. Mol. Cell. Endocrinol. 118:1996a;113-123.
21. Li A.W., Too C.K.L., Knee R., Wilkinson M., Murphy P.R. FGF-2 antisense RNA encodes a nuclear protein with MutT-like antimutator activity. Mol. Cell. Endocrinol. 133:1997;177-182.
22. Li A.W., Too C.K.L., Murphy P.R. The basic fibroblast growth factor (FGF-2) antisense RNA (GFG) is translated into a MutT-related protein in vivo. Biochem. Biophys. Res. Commun. 223:1996b;19-23.
23. Morrison R.S., Yamaguchi F., Saya H., Bruner J.M., Yahanda A.M., Donehower L.A. et al. Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J. Neurooncol. 18:1994;207-216.
24. Morse D.P., Bass B.L. Detection of inosine in messenger RNA by inosine-specific cleavage. Biochemistry. 36:1997;8429-8434.
25. Murphy P.R., Sato Y., Knee R. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol. Endocrinol. 6:1992;877-884.
26. Murphy P.R., Knee R.S. Identification and characterization of an antisense RNA transcript (gfg) from the basic fibroblast growth factor gene in human and rat cells. Mol. Endocrinol. 8:1994;852-859.
27. Murphy P.R., Myal Y., Sato Y., Sato R., West M., Friesen H.G. Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas. Mol. Endocrinol. 3:1989;225-231.
28. Paul M.S., Bass B.L. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J. 17:1998;1120-1127.
29. Polson A.G., Bass B.L., Casey J.L. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature. 380:1996;454-456.
30. Powell P., Klagsbrun M. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells. Exp. Cell. Res. 209:1993;224-230.
31. Prats H., Kaghad M., Prats A.C., Klagsbrun M., Lelias J.M., Liauzun P. et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl. Acad. Sci. USA. 86:1989;1836-1840.
32. Redekop G., Naus C. Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J. Neurosurg. 82:1995;83-90.
33. Saccomanno I., Bass B.L. The cytoplasm of Xenopus oocytes contains a factor that protects double-stranded RNA from adenosine-to-inosine modification. Mol. Cell. Biol. 14:1994;5425-5432.
34. Saccomanno L., Bass B.L. A minor fraction of basic fibroblast growth factor mRNA is deaminated in Xenopus stage VI and matured oocytes. RNA. 5:1999;39-48.
35. Savage M.P., Fallon J.F. FGF-2 mRNA and its antisense message are expressed in a developmentally specific manner in the chick limb bud and mesonephros. Dev. Dyn. 202:1995;343-353.
36. Scadden A.D., Smith C.W. A ribonuclease specific for inosine-containing RNA: a potential role in antiviral defence? EMBO J. 16:1997;2140-2149.
37. Seeburg P. The role of RNA editing in controlling glutamate receptor channel properties. J. Neurochem. 66:1996;1-5.
38. Smyth C., Knee R., Wilkinson M., Murphy P.R. Decline in basic fibroblast growth factor (FGF-2) mRNA expression in female at hypothalamus at puberty. J. Neuroendocrinol. 9:1997;151-159.
39. Takahashi J.A., Fukumoto M., Igarashi K., Oda Y., Kikuchi H., Hatanaka M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76:1992;792-798.
40. Theillet C., Le Roy X., De Lapeyriere O., Grosgeorges J., Adnane J., Raynaud S.D. et al. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene. 4:1989;915-922.
41. Touriol C., Morillon A., Gensac M.C., Prats H., Prats A.C. Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3′-untranslated region between alternative polyadenylation sites. J. Biol. Chem. 274:1999;21402-21408.
42. Vaccarino F.M., Schwartz M.L., Raballo R., Nilsen J., Rhee J., Zhou M. et al. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat. Neurosci. 2:1999;246-253.
43. Volk R., Koster M., Poting A., Hartmann L., Knochel W. An antisense transcript from the Xenopus laevis bFGF gene coding for an evolutionarily conserved 24 kd protein. EMBO J. 8:1989;2983-2988.
44. Westermann R., Unsicker K. Basic fibroblast growth factor (bFGF) and rat C6 glioma cells: regulation of expression, absence of release, and response to exogenous bFGF. Glia. 3:1990;510-521.